PolyNovo Ltd (PNV):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:PolyNovo Ltd (PNV) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7367
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PolyNovo Ltd (PolyNovo), formerly Calzada Ltd, is a medical device company that develops, manufactures and commercializes biodegradable polymers for use in medical devices. The company provides products such as biodegradable temporizing matrix and negative pressure wound therapy dressing systems. Its products are used in the treatment of burns, surgical wounds, hernia repair, trauma, orthopaedics and reconstructive surgery. PolyNovo develops its products using novosorb biodegradable polymer technology. PolyNovo’s negative pressure wound therapy dressing systems are used in medical procedures to remove excess fluid from chronic wounds such as pressure sores. The company distributes its products through a network of distributors. PolyNovo is headquartered in Melbourne, Victoria, Australia.

PolyNovo Ltd (PNV) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PolyNovo Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PolyNovo Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
PolyNovo Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PolyNovo Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
PolyNovo Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PolyNovo Ltd, Medical Equipment, Deal Details 10
Partnerships 10
PolyNovo Biomaterials Enters Into Licensing Agreement With NovoPlastiq For NovoSorb 10
PolyNovo to Enter into Co-Development Agreement with Establishment Labs 11
PolyNovo to Enter into Agreement with Medical Device Company 12
Equity Offering 13
PolyNovo Raises USD12.7 Million in Rights Offering of Shares 13
PolyNovo Raises USD5.6 Million in Private Placement of Shares 14
PolyNovo Ltd – Key Competitors 15
PolyNovo Ltd – Key Employees 16
PolyNovo Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Jan 23, 2018: PolyNovo: COO, CFO & Company Secretary 18
Other Significant Developments 19
May 19, 2017: PolyNovo: Business update and earnings guidance 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
PolyNovo Ltd, Medical Equipment, Key Facts, 2018 2
PolyNovo Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
PolyNovo Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PolyNovo Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
PolyNovo Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PolyNovo Ltd, Deals By Market, 2012 to YTD 2018 8
PolyNovo Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
PolyNovo Biomaterials Enters Into Licensing Agreement With NovoPlastiq For NovoSorb 10
PolyNovo to Enter into Co-Development Agreement with Establishment Labs 11
PolyNovo to Enter into Agreement with Medical Device Company 12
PolyNovo Raises USD12.7 Million in Rights Offering of Shares 13
PolyNovo Raises USD5.6 Million in Private Placement of Shares 14
PolyNovo Ltd, Key Competitors 15
PolyNovo Ltd, Key Employees 16
PolyNovo Ltd, Subsidiaries 17

List of Figures
PolyNovo Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
PolyNovo Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
PolyNovo Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
PolyNovo Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
PolyNovo Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
PolyNovo Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
PolyNovo Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
PolyNovo Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[PolyNovo Ltd (PNV):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • J.E. Dunn Construction Group Inc:企業の戦略的SWOT分析
    J.E. Dunn Construction Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Metsa Tissue Corporation:企業の戦略的SWOT分析
    Metsa Tissue Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Scotiabank Peru S.A.A.
    Scotiabank Peru S.A.A. - Strategy, SWOT and Corporate Finance Report Summary Scotiabank Peru S.A.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Technical Olympic SA:企業の戦略・SWOT・財務情報
    Technical Olympic SA - Strategy, SWOT and Corporate Finance Report Summary Technical Olympic SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • DCO Energy LLC-エネルギー分野:企業M&A・提携分析
    Summary DCO Energy LLC (DCO) is an energy development company that constructs, operates, develops, and maintains cogeneration and renewable energy projects across the US. The company's services include financing, performance testing, equipment and systems analyses, retro-commissioning services, ener …
  • CCP Technologies Ltd (AGX)-製薬・医療分野:企業M&A・提携分析
    Summary CCP Technologies Ltd (CCP), formerly Agenix Ltd is a biotechnology company that offers molecule drugs. The company develops small molecule drugs and monoclonal antibody-based diagnostics for the treatment of various diseases. It develops DiagnostIQ rapid point-of-care human diagnostic techno …
  • BYD Company Limited:企業の戦略・SWOT・財務分析
    BYD Company Limited - Strategy, SWOT and Corporate Finance Report Summary BYD Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Windtree Therapeutics Inc (WINTD):企業の財務・戦略的SWOT分析
    Windtree Therapeutics Inc (WINTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • C. R. Bard, Inc.:企業のM&A・事業提携・投資動向
    C. R. Bard, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's C. R. Bard, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Philex Mining Corp:企業の戦略・SWOT・財務情報
    Philex Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Philex Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • 3M Company:企業の戦略・SWOT・財務分析
    3M Company - Strategy, SWOT and Corporate Finance Report Summary 3M Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sumitomo Heavy Industries Ltd (6302)
    Sumitomo Heavy Industries Ltd (6302) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • GOBARTO S.A.:戦略・SWOT・企業財務分析
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Innovent Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company offers monoclonal antibodies such as IBI301, IBI302 and IBI303, among others. Its products are used for the treatment of non-Hodgkin’s lymph …
  • Actua Corporation:企業のM&A・事業提携・投資動向
    Actua Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Actua Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • A123 Systems LLC:企業の戦略的SWOT分析
    A123 Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • TransGenic Inc (2342):企業の財務・戦略的SWOT分析
    TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CaixaBank SA:企業の戦略・SWOT・財務情報
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Lentigen Technology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lentigen Technology Inc (Lentigen), a subsidiary of Miltenyi Biotec GmbH, is a provider of gene delivery and expression technology solutions. The company provides clinical trial support in viral vector product development and clinical applications, among others. Its lentiviral vectors finds …
  • Strike Energy Ltd (STX):企業の財務・戦略的SWOT分析
    Summary Strike Energy Ltd (Strike Energy) is an oil and gas exploration and development company that explores, produces, and develops shale oil and gas. The company provides properties such as Eagle Ford Shale, Permian Basin, Cooper Basin, gulf coast conventional, and others. It has exploration and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆